Delivery Order SPE2DB22D2007-SPE2DB24FJ2FT

Award Date 5/6/24
Potential Completion Date 5/7/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $3,687.28 firm-fixed-price delivery order contract to the corporate office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is to provide the product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML" and has an ultimate completion date of May 22, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a wide range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,241.34 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which runs through June 2024, is for the supply of the pharmaceutical product "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML." Amerisourcebergen, a major supplier of pharmaceuticals and medical supplies to the federal government, is providing these products to support DLA Troop Support Medical's mission to procure...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $15,271.60 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of the pharmaceutical product "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML" and has a completion date of May 30, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC,...
The Defense Logistics Agency (DLA) awarded a $1,053.76 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. This contract is for the provision of the drug "ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML" and does not have a set-aside designation. Amerisourcebergen also holds a larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued up to...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $6,322.56 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of the pharmaceutical product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML" with a completion date of May 21, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $4,180.68 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4564367528 ! ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML. This contract has an ultimate completion date of April 22, 2024. Amerisourcebergen, a major pharmaceutical distributor, also holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 31, 2025, which serves as...
The U.S. government awarded a Delivery Order contract worth $1,669.95 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the provision of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical, with a period of performance through May 17, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00, which serves as the...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $19,092.48. The contract is for the supply of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and test kits. Amerisourcebergen also holds a larger Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract, valued at $883,425.75, to Amerisourcebergen Drug Corp's Corporate Office division. This Firm Fixed Price contract is for the delivery of a wide range of pharmaceutical products and medical supplies, including prescription medications, over-the-counter drugs, and critical care materials such as syringes and test kits. The contract has an ultimate completion date of May 3, 2024. Amerisourcebergen, a major pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, valued at $25,129.86. The contract is for the supply of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and test kits. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ2FT
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $19,104.32 to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government. This delivery order, which has a firm fixed-price pricing type, is for the provision of the pharmaceutical product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML" and has an ultimate completion date of May 7, 2024.

Amerisourcebergen Drug Corp, through its Corporate Office division, holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 8/5/24, 9:55 AM